These recently funded projects aim to increase scientific knowledge and advance therapeutics for pediatric heart disease.

The co-directors of CHOP’s Cardiac Center highlight some of the biggest recent breakthroughs in pediatric cardiology along with one change they would like to see.

Meet six trailblazing physicians who, in the face of incredible adversity, helped shape the field of cardiology.

CHOP researchers have found that modifying bioprosthetic heart valves (BHV) with a polymer known as POZ prevents structural degeneration of the valve.

A new study by researchers at CHOP finds children with multi-system inflammatory syndrome (MIS-C), a post-infectious complication of SARS-Co-V2, regained normal cardiac function within approximately three months of initial treatment.

Worried about the risk of myocarditis? A CHOP expert helps discern the myths from the facts so you can make an informed decision about vaccinating your child.

You could save a life by learning the warning signs of sudden cardiac arrest and how to take action. Take steps now to be prepared in an emergency.

Fainting spells can sometimes be the first warning sign of undiagnosed heart disease. A CHOP expert explains what to look out for and when to call your pediatrician.

CHOP researchers participated in clinical trial that showed valsartan has a measurable benefit for patients with early-stage hypertrophic cardiomyopathy.

A year after the signing of the Abraham Accords — a declaration recognizing the importance of strengthening peace around the world — leaders and clinicians from CHOP hosted a meeting to share knowledge and research with pediatric experts from CHOP, the U.A.E. and Israel.